Argon Medical Devices — maker of devices for interventional procedures — announced today that it has bought plastic injection molding provider Matrex Mold and Tool.
The financial terms of the deal were not disclosed. Frisco, Texas–based Argon has been a customer of Wisconsin-based Matrex for more than 25 years.
Get the full story on our sister site Medical Tubing + Extrusion.
By Stewart Eisenhart, Emergo Group
A new discussion paper from the US Food and Drug Administration identifies challenges to developing effective regulatory oversight of 3D printed medical devices used in patient point of care (PoC) settings, and lays out potential regulatory approaches for such devices.
Get the full story here at the Emergo Group’s blog.
The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MedicalDesignandOutsourcing.com or its employees.
The National Capital Consortium for Pediatric Device Innovation recently announced five electrophysiology devices that could monitor and treat congenital heart disease and arrhythmia in pediatric patients.
The five winners of the annual NCC-PDI “Make Your Medical Device Pitch for Kids!” competition will share a $150,000 grant funding from the FDA to support the advancement of pediatric medical devices.
The competition was conducted by NCC-PDI partner Medtech Innovator and was part of the 9th annual Symposium on Pediatric Device Innovation.
Congenital heart defects are the most common type of birth defect, according to the Centers for Disease Control and Prevention. It affects six out of 1,000 babies born in the U.S. each year and is often complicated by arrhythmias. There has been a lot of advances in technologies to care for adult arrhythmias within the last 10 years, but pediatrics is slower to innovate with only five devices approved for use in childr…
Quasar Engineering announced that it acquired TE Connectivity subsidiary Creganna Medical.
Through the acquisition of Creganna, which constitutes TE Connectivity’s medical operations in Singapore, Quasar aims to expand its footprint in Asia, complement its capabilities and add an experienced team in Singapore, which it considers an important global medical device hub.
“I am very excited to welcome the new capabilities that the Singapore team will bring to Quasar” Quasar Medical CEO Alex Wallstein said in a news release. “The addition of the Singapore operation strengthens Quasar Medical as one of the leading suppliers for the minimally-invasive interventional segment and broadens our value proposition to our customers.
“We look forward to invest and further grow capacity in Singapore and extend a warm welcome to the 120 employees of the Singapore operation.”
BD (NYSE:BDX) this week announced that it committed $500,000 to improve the quality of care and reduce health inequities in the U.S.
Franklin Lakes, N.J.-based BD will award health-focused relief organization Americares $250,000 annually for the next two years to support a multi-year project that will collect demographic and patient health outcome data from free and charitable clinics nationwide.
“We know that racial and ethnic groups in the United States experience worse health outcomes for certain conditions and are statistically more likely to face barriers that make it more difficult to access quality care,” BD CEO and president Tom Polen said in a news release. “Investing in the health of our communities is a pillar of the BD environmental, social and governance strategy. By supporting this important, first-of-its-kind initiative, we’re helping to empower U.S. free and charitable clinics to measure and track the degree to which their health care services a…
Fareva and ApiJect Systems today announced a licensing agreement to fill-finish more than 500 million injectable drug doses per year.
Under the agreement, Fareva intends to invest more than $56.5 million to install three blow-fill-seal production lines with support from the Government of France through the France Relance industry initiative, as well as the Investments for the Future Program (PIA).
Get the full story at our sister site, Drug Delivery Business News.
Evonik announced that it invested in startup Revivo BioSystems to support the development and commercialization of its technology.
Essen, Germany-based Evonik said in a news release that Revivo BioSystems develops technology that uses a realistic 4D model of human skin to test chemical, cosmetic and pharmaceutical compounds, offering an alternative to animal testing that can be quicker, more reliable and more cost-efficient.
Singapore-based Revivo’s organ-on-a-chip technology automates testing and sampling procedures in addition to simulating the interaction of human skin with the substance being tested. Skin tissues grown in a laboratory (or a human skin sample) are placed on biochips that are supplied with nutrients and reagents, creating a micro-environment for the tissue models, which reproduce the architecture and functions of skin.
Evonik said consumers prefer substances that haven’t been tested on animals, while more than 40 countries …
Fresenius Medical Care announced today that it received a positive rating for its efforts in climate protection.
According to a news release, the company garnered a “B” rating from the nonprofit organization CDP, marking its place in the second-highest categories.
Fresenius said it received a “B” in the climate area and a “B-” in the water area. The company said the rating solidifies its place as one of the leading companies in the healthcare sector with regard to climate protection measures.
Companies listed in “A” and “B” categories are characterized by transparency, coordinated climate protection measures and the implementation of corresponding best-practice approaches.
Artio Medical today announced that it received the green light to build commercial manufacturing operations in Kansas.
The City council in Olathe, Kansas approved a development agreement that granted land to Prairie Village, Kansas-based Artio Medical to build two commercial manufacturing buildings. The company plans to build an initial 50,000+ sq. ft facility on the 18-acre parcel land.
Get the full story on our sister site, MassDevice.
Integrated Computer Solutions (ICS) and Variscite announced today that they are collaborating on new solutions in the embedded market.
The collaboration aims to offer a complete hardware and software solution to customers in the market, with Variscite’s SoM (system on module) solutions and ICS’ best-in-class software services set to provide a complete system solution that offers customers accelerated development, decreased development cost and more reliable continuity of maintenance and support, according to a news release.
Waltham, Massachusetts-based ICS said Variscite is the only SoM vendor member in the NXP Platinum Parner program, assuring the highest quality and stable supply for its product portfolio, which includes VAR-SOM and DART.
ICS’ software solutions have already been implemented on Variscite’s modules in several projects to allow customers to have a significantly accelerated product release.
“We are ver…
Veranex today announced that it has acquired medtech design firm Worrell for an undisclosed amount.
Raleigh, N.C.-based Veranex delivers strategic, operations and financial benefits to medical device companies and engineers that are developing breakthrough technologies, according to the company. The acquisition of Worrell will expand its offerings and geographic reach.
“The addition of Worrell strengthens Veranex’s offerings as the leading global provider in the medical device and biotech space. By enhancing our human-centered design capabilities with a focus on Phase 0 strategy, design conceptualization, and human factors services, we complement our existing ISO-certified Phase 1-4 engineering and pilot-scale manufacturing capabilities,” Veranex executive chairperson Patrick Donnelly said in a news release. “We’re thrilled to welcome the employees of Worrell to Veranex.”
Worrell’s president Kai Worrell will join Veranex as president of its p…
Movia Robotics this week announced that it has launched its TheraPal line of digital health aides for autism spectrum disorder and other intellectual or developmental disabilities.
Bristol, Connecticut-based Movia Robotics released its TheraPal Progress Tracker, TheraPal Home and TheraPal Clinical assist aides for use in homes and clinician offices. The robotic aides are designed to be used by parents, therapists and other healthcare professionals for the development and learning of individuals with neurodevelopmental or intellectual challenges, according to the company.
Movia’s robot-assisted intervention is a friendly digital tool that uses applied behavior analysis and other evidence-based methods with gamification techniques to allow children and older individuals to practice a broad range of life skills and confidence-building activities.
The fully-configurable system has modules for cognitive training, communication training, practice and edu…